Inovio Biomedical Corporation To Present At BIO Drug/Device Summit 2006

SAN DIEGO--(BUSINESS WIRE)--Inovio Biomedical Corporation (AMEX:INO), a late stage developer/enabler of oncology and DNA vaccine therapies using electroporation to deliver drugs and nucleic acids, announced today that the Company's president and CEO, Avtar Dhillon, MD, will present a corporate overview on Inovio at BIO Drug/Device Summit 2006 on Monday, Dec. 4th, at 4:35 p.m. Pacific Time at the Hyatt La Jolla in San Diego.